ArticleCancer cell international2026

PHI-501, a dual inhibitor of RAF and DDR1/2, overcomes MAPK drug resistance in Melanoma.

Sue Min Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.